Hetero seeks emergency use authorisation for Merck's antiviral drug
Clinical trial shows molnupiravir helps in early recovery in non-hospitalised Covid-19 patients09-07-2021
09-07-2021
Procter & Gamble Health Ltd - 500126 - Compliance Certificate As Per Reg. 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended June 30,2021
With reference to the above we are enclosing herewith compliance certificate as per Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended June 30,2021.08-07-2021
Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to above captioned subject, we are enclosing herewith certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30,2021.08-07-2021
Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Zeal ShahDesignation :- Any Other08-07-2021
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents, KFin Technologies Pvt Limited, regarding the issue of duplicate share certificate(s) to the shareholder(s) of the Company.06-07-2021
Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from July 1, 2021 until 48 hours from the publication of the audited financial results for quarter and year ended June 30, 2021. Kindly take the same on record.30-06-2021
Procter & Gamble Health Ltd - 500126 - Appointment Of Ms. Zeal Shah As Compliance Officer Of The Company
We would like to inform you that Ms. Zeal Shah has been appointed as Compliance Officer of the Company under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015 effective July 1, 2021. Ms. Zeal Shah is a qualified Company Secretary (ACS 52286) and has also done her Bachelors in Law. She has about 4 years of work experience in the field of corporate and securities laws. We request you to take the same on record.30-06-2021
Procter & Gamble Health Ltd - 500126 - Appointment Of Ms. Zeal Shah As Compliance Officer Of The Company
We would like to inform you that Ms. Zeal Shah has been appointed as Compliance Officer of the Company under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015 effective July 1, 2021. Ms. Zeal Shah is a qualified Company Secretary (ACS 52286) and has also done her Bachelors in Law. She has about 4 years of work experience in the field of corporate and securities laws. We request you to take the same on record.30-06-2021
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that Ms. Preeti Bishnoi has tendered her resignation as the Company Secretary and Compliance Officer of the Company with effect from close of business hours on June 30, 2021.30-06-2021
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment.17-06-2021